SHIRE PHARMACEUTICALS LIMITED

1. Company facts

Status

active

Lifecycle

🌳 Mature — Long-running with flat or slow growth. Steady cash, limited upside.

Jurisdiction

england-wales

Registered office

1 Kingdom Street, London, W2 6BD, United Kingdom

SIC codes

21100 — SIC 21100; 46460 — SIC 46460

Accounts next due

2026-12-31

Confirmation statement next due

2026-07-12

2. Directors (2 active)

MEMIS, Seyda Atadan

director · appointed 2022-08-01 · born 3/1979 (age 47)

PAGE, Marc Stuart

director · appointed 2025-08-19 · born 2/1985 (age 41)

3. Shareholders (1 active)

Takeda Uk Limited

75-100% shares · 75-100% voting · board control

4. Group structure

Takeda Uk Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

Takeda Uk Limited

Corporate parent · 75-100%

5. Security

2 total charges (0 outstanding, 2 satisfied).

Headline verdict

Opportunity score

73/100 (Strong)

Owner dependency

moderate — 58/100

Red flags

0 high · 0 medium · 1 low